Interleukin-10 influences susceptibility to experimental autoimmune thyroiditis independently of the H-2 gene

Yu,Zhenqian; Liu,Tong; Liu,Shanshan; Zou,Hongjin; Sun,Xuren; Shi,Xiaoguang; Li,Yushu; Shan,Zhongyan; Teng,Weiping

doi:10.3892/ijmm.2014.2025

Interleukin-10 influences susceptibility to experimental autoimmune thyroiditis independently of the H-2 gene

Authors:
- Zhenqian Yu
- Tong Liu
- Shanshan Liu
- Hongjin Zou
- Xuren Sun
- Xiaoguang Shi
- Yushu Li
- Zhongyan Shan
- Weiping Teng
View Affiliations

Affiliations: Department of Endocrinology and Metabolism, Institute of Endocrinology, Liaoning Provincial Key Laboratory of Endocrine Diseases, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China, Department of Gastroenterology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China
Published online on: December 5, 2014 https://doi.org/10.3892/ijmm.2014.2025
Pages: 413-424

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Both BALB/c and C57BL/6 mice are relatively resistant to experimental autoimmune thyroiditis (EAT) due to their histocompatibility (H-2) genetic background; however, susceptibility to EAT is also influenced by other genetic factors. Given the curative effect of interleukin-10 (IL-10) on thyroiditis, in the present study, we investigated whether IL-10 functions as a non-H-2 genetic factor that influences the development of EAT in mice with an EAT-resistant genetic background. In this study, we observed that the development of EAT could be induced in both C57BL/6 IL-10‑deficient (IL-10-/-) and BALB/c IL-10-/- female mice following immunization with mTg, which indicated that IL-10 may be a non-H-2 factor that affects susceptibility to EAT. However, the role of the H-2 factor remained dominant, as the incidence of EAT was low and its severity was mild. We further investigated the underlying pathogenic mechanisms of EAT in IL-10-/- female mice. We found that Th1 cells, Th17 cells, CD4+CD25+Foxp3+ regulatory T cells, and their associated cytokines were all involved in the development of EAT. The absence of IL-10 promoted the polarization of pathogenic cells and the production of associated cytokines, and suppressed the proliferation of protective T cell clones. Together, these factors may contribute to the development of EAT in IL-10-/- mice. In conclusion, our data demonstrate that IL-10 plays a critical role in the susceptibility to EAT, and a better understanding of the role of IL-10 in autoimmune thyroiditis may facilitate the development of novel strategies for the treatment of autoimmune thyroid diseases.

View Figures

View References

1	Rose NR, Twarog FJ and Crowle AJ: Murine thyroiditis: importance of adjuvant and mouse strain for the induction of thyroid lesions. J Immunol. 3:698–704. 1971.
2	Braley-Mullen H, Johnson M, Sharp GC and Kyriakos M: Induction of experimental autoimmune thyroiditis in mice with in vitro activated splenic T cells. Cell Immunol. 1:132–143. 1985. View Article : Google Scholar
3	Ganesh BB, Bhattacharya P, Gopisetty A and Prabhakar BS: Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity. J Interferon Cytokine Res. 10:721–731. 2011. View Article : Google Scholar
4	Kong YC: Experimental autoimmune thyroiditis in the mouse. Curr Protoc Immunol. Chapter 15: Unit 15.7. 2007. View Article : Google Scholar
5	Vladutiu AO and Rose NR: Autoimmune murine thyroiditis relation to histocompatibility (H-2) type. Science. 4014:1137–1139. 1971. View Article : Google Scholar
6	Beisel KW, Kong YM, Babu KS, David CS and Rose NR: Regulation of experimental autoimmune thyroiditis: influence of non-H-2 genes. J Immunogenet. 4:257–265. 1982. View Article : Google Scholar
7	Moore KW, de Waal Malefyt R, Coffman RL and O’Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 19:683–765. 2001. View Article : Google Scholar : PubMed/NCBI
8	Saraiva M and O’Garra A: The regulation of IL-10 production by immune cells. Nat Rev Immunol. 3:170–181. 2010. View Article : Google Scholar
9	Kühn R, Löhler J, Rennick D, Rajewsky K and Müller W: Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 2:263–274. 1993. View Article : Google Scholar
10	Batteux F, Trebeden H, Charreire J and Chiocchia G: Curative treatment of experimental autoimmune thyroiditis by in vivo administration of plasmid DNA coding for interleukin-10. Eur J Immunol. 3:958–963. 1999. View Article : Google Scholar
11	Fang Y, Sharp GC and Braley-Mullen H: Interleukin-10 promotes resolution of granulomatous experimental autoimmune thyroiditis. Am J Patho. l72:1591–1602. 2008. View Article : Google Scholar
12	Teng XC, Jia XK, Fan CL, Wang H, Guo R and Teng WP: Extraction, purification and identification thyroglobulin of mouse. Chin J Med Med. 12:1467–1469. 2007.In Chinese.
13	Gangi E, Vasu C, Cheatem D and Prabhakar BS: IL-10-producing CD4⁺CD25⁺ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis. J Immunol. 11:7006–7013. 2005. View Article : Google Scholar
14	Xue H, Wang W, Shan Z, Li Y, Teng X, Gao Y, Fan C and Teng W: Dynamic changes of CD4⁺CD25⁺ regulatory T cells in NOD H-2^h4 mice with iodine-induced autoimmune thyroiditis. Biol Trace Elem Res. 1:292–301. 2011. View Article : Google Scholar
15	Gangi E, Vasu C, Cheatem D and Prabhakar BS: IL-10-producing CD4⁺CD25⁺ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis. J Immunol. 11:7006–7013. 2005. View Article : Google Scholar
16	Vasu C, Dogan RN, Holterman MJ and Prabhakar BS: Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4⁺/CD25⁺ T cells and suppresses experimental autoimmune thyroiditis. J Immunol. 11:5511–5522. 2003. View Article : Google Scholar
17	El Fassi D, Banga JP, Gilbert JA, Padoa C, Hegedüs L and Nielsen CH: Treatment of Graves’ disease with rituximab specifically reduces the production of thyroid stimulating auto-antibodies. Clin Immunol. 130:252–258. 2009. View Article : Google Scholar
18	Tang H, Mignon-Godefroy K, Meroni PL, Garotta G, Charreire J and Nicoletti F: The effects of a monoclonal antibody to interferon-gamma on experimental autoimmune thyroiditis (EAT): prevention of disease and decrease of EAT-specific T cells. Eur J Immunol. 1:275–278. 1993. View Article : Google Scholar
19	Shi L, Bi M, Yang R, Zhou J, Zhao s, Fan C, Shan Z, Li Y and Teng W: Defective expression of regulatory B cells in iodine-induced autoimmune thyroiditis in non-obese diabetic H-2(h4) mice. J Endocrinol Invest. 37:43–50. 2014. View Article : Google Scholar : PubMed/NCBI
20	Verginis P, Li HS and Carayanniotis G: Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4⁺CD25⁺ T cells. J Immunol. 174:7433–7439. 2005. View Article : Google Scholar : PubMed/NCBI
21	Tomazic V, Rose NR and Shreffler DC: Autoimmune murine thyroiditis. IV. Localization of genetic control of the immune response. J Immunol. 3:965–969. 1974.
22	Kalampokis I, Yoshizaki A and Tedder TF: IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res Ther. Feb 11–2013. View Article : Google Scholar : PubMed/NCBI
23	Wang SH, Bretz JD, Phelps E, Mezosi E, Arscott PL, Utsugi S and Baker JR Jr: A unique combination of inflammatory cytokines enhances apoptosis of thyroid follicular cells and transforms nondestructive to destructive thyroiditis in experimental auto-immune thyroiditis. J Immunol. 5:2470–2474. 2002. View Article : Google Scholar
24	Kennedy MK, Torrance DS, Picha KS and Mohler KM: Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol. 149:2496–2505. 1992.PubMed/NCBI
25	Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW and O’Garra A: IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol. 10:3444–3451. 1991.
26	Todd I, Pujol-Borrell R, Hammond LJ, Bottazzo GF and Feldmann M: Interferon-gamma induces HLA-DR expression by thyroid epithelium. Clin Exp Immunol. 2:265–273. 1985.
27	Maddur MS, Miossec P, Kaveri SV and Bayry J: Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol. 1:8–18. 2012. View Article : Google Scholar
28	Figueroa-Vega N, Alfonso-Perez M, Benedicto I, Sanchez-Madrid F, Gonzalez-Amaro R and Marazuela M: Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto’s thyroiditis. J Clin Endocrinol Metab. 95:953–962. 2010. View Article : Google Scholar
29	Li D, Cai W, Gu R, Zhang Y, Zhang H, Tang K, Xu P, Katirai F, Shi W, Wang L, Huang T and Huang B: Th17 cell plays a role in the pathogenesis of Hashimoto’s thyroiditis in patients. Clin Immunol. 149:411–420. 2013. View Article : Google Scholar : PubMed/NCBI
30	Horie I, Abiru N, Nagayama Y, Kuriya G, Saitoh O, Ichikawa T, Iwakura Y and Eguchi K: T helper type 17 immune response plays an indispensable role for development of iodine-induced autoimmune thyroiditis in nonobese diabetic-H2h4 mice. Endocrinology. 11:5135–5142. 2009. View Article : Google Scholar
31	Huber S, Gagliani N, Esplugues E, O’Connor W Jr, Huber FJ, Chaudhry A, Kamanaka M, Kobayashi Y, Booth CJ, Rudensky AY, Roncarolo MG, Battaglia M and Flavell RA: Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3⁺ regulatory CD4⁺ T cells in an interleukin-10-dependent manner. Immunity. 4:554–565. 2011. View Article : Google Scholar
32	Sakaguchi S, Yamaguchi T, Nomura T and Ono M: Regulatory T cells and immune tolerance. Cell. 5:775–787. 2008. View Article : Google Scholar
33	Hori S, Nomura T and Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science. 299:1057–1061. 2003. View Article : Google Scholar : PubMed/NCBI
34	Fontenot JD, Gavin MA and Rudensky AY: Foxp3 programs the development and function of CD4(+)CD25(+) regulatory T cells. Nat Immunol. 4:330–336. 2003. View Article : Google Scholar : PubMed/NCBI
35	Murai M, Turovskaya O, Kim G, Madan R, Karp CL, Cheroutre H and Kronenberg M: Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol. 11:1178–1184. 2009. View Article : Google Scholar